Skip to content
Home/Companies/Biotech/Bluu Biosciences

Bluu Biosciences

Biotech·Germany·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Bluu Biosciences?

Bluu Biosciences is currently owned by DX Ventures through DX Ventures (CVC Evergreen Vehicle) (2021 vintage), since 2021.

Hand-verified · updated 2026-07-03

DX Ventures
Investor
DX Ventures
DX Ventures (CVC Evergreen Vehicle) · 2021 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from DX Ventures (CVC Evergreen Vehicle)

Other portfolio companies in the same fund.

Alpagga
Active
E-commerceFrance· 2024
Qashier
Qashier
Active
FintechSingapore· 2023
Yodawy
Yodawy
Active
HealthcareEgypt· 2023
Amuse
Exited 2024
ConsumerSouth Korea· 2022
to
Dat Bike
Dat Bike
Active
MobilityVietnam· 2022
Haddock
Haddock
Active
SoftwareSpain· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Bluu Biosciences

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Bluu Biosciences?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Bluu Biosciences.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue